Search Results - Nathalie Lavis

  • Showing 1 - 9 results of 9
Refine Results
  1. 1
    Cover Image

    Immunogenicity and safety of the 2015 Southern Hemisphere formulation of a split-virion inactivated quadrivalent vaccine by Cecilia Montalban, May Book Montellano, Jaime Santos, Nathalie Lavis

    Published 2018
    Connect to this object online.
    Book

    Save to List
    Saved in:
  2. 2
    Cover Image

    Rapid safety assessment of a seasonal intradermal trivalent influenza vaccine by Marc Demeulemeester, Nathalie Lavis, Yohan Balthazar, Patrice Lechien, Stéphane Heijmans

    Published 2017
    Connect to this object online.
    Book

    Save to List
    Saved in:
  3. 3
    Cover Image

    Immunogenicity and safety of the Southern Hemisphere 2015 formulation of Vaxigrip® by Mathilde Latreille-Barbier, Regine Rouzier, Beatrice Astruc, Nathalie Lavis, Yves Donazzolo

    Published 2017
    Connect to this object online.
    Book

    Save to List
    Saved in:
  4. 4
    Cover Image

    Immunogenicity and safety of a trivalent inactivated influenza vaccine produced in Shenzhen, China by Zhaojun Mo, Yi Nong, Shuzhen Liu, Ming Shao, Xueyan Liao, Kerry Go, Nathalie Lavis

    Published 2017
    Connect to this object online.
    Book

    Save to List
    Saved in:
  5. 5
    Cover Image

    Immunogenicity and safety of a quadrivalent inactivated influenza vaccine in pregnant women: a randomized, observer-blind trial by Timo Vesikari, Miia Virta, Seppo Heinonen, Cécile Eymin, Nathalie Lavis, Anne Laure Chabanon, Viviane Gresset-Bourgeois

    Published 2020
    Connect to this object online.
    Book

    Save to List
    Saved in:
  6. 6
    Cover Image

    Safety of a quadrivalent influenza vaccine in Vietnamese healthy subjects aged 6 months and older by Vu Dinh Thiem, Anne-Laure Chabanon, Marion Fournier, Nathalie Lavis, Nguyen Dang Quang, Vu Hai Ha, Melvin Sanicas

    Published 2021
    Connect to this object online.
    Book

    Save to List
    Saved in:
  7. 7
    Cover Image

    Immunogenicity and safety of a trivalent inactivated influenza vaccine produced in Shenzhen, China versus a comparator influenza vaccine: a phase IV randomized study by Yuemei Hu, Kai Chu, Nathalie Lavis, Xiaoling Li, Bill Liang, Shuzhen Liu, Ming Shao, Jean-Denis Shu, Cynthia Tabar, Sandrine Samson

    Published 2019
    Connect to this object online.
    Book

    Save to List
    Saved in:
  8. 8
    Cover Image

    Immunogenicity and safety of a split-virion quadrivalent influenza vaccine in adults 18-60 years of age in the Republic of Korea by Won Suk Choi, Ji Yun Noh, Jacob Lee, Jun Yong Choi, Jin-Soo Lee, Moo Soo Kim, Hee Soo Kim, Joon Bang, Nathalie Lavis, Woo Joo Kim

    Published 2018
    Connect to this object online.
    Book

    Save to List
    Saved in:
  9. 9
    Cover Image

    Immunological non-inferiority and safety of a quadrivalent inactivated influenza vaccine versus two trivalent inactivated influenza vaccines in China: Results from two studies by Xiaoqiang Liu, Juliana Park, Shengli Xia, Bin Liang, Shuangmin Yang, Yanxia Wang, Olga Syrkina, Nathalie Lavis, Shuzhen Liu, Chenyan Zhao, Jian Ding, Jieqiong Hu, Sandrine I. Samson, Iris A. de Bruijn, for the FSQ01 and FSQ02 Study Groups

    Published 2022
    Connect to this object online.
    Book

    Save to List
    Saved in:

Search Tools: